Skip to content

Impact of CPAP Level on V/Q Mismatch in Premature Infants

Impact of Continuous Positive Airway Pressure Level on Ventilation/Perfusion Mismatch in Premature Infants: a Phase II Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02983825
Enrollment
21
Registered
2016-12-06
Start date
2017-02-01
Completion date
2020-02-13
Last updated
2021-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant, Premature, Diseases, Respiratory Insufficiency Syndrome of Newborn

Keywords

CPAP, Bronchopulmonary Dysplasia, Ventilator Induced Lung Injury, V/Q mismatch

Brief summary

Continuous positive airway pressure (CPAP) is used in premature infants to maintain lungs open and facilitate gas exchange. When ventilation/perfusion (V/Q) mismatch is present, areas of the lung that are open for gas exchange do not match up with the areas of the lung that are receiving blood for gas exchange. This study measure the responsiveness of V/Q mismatch to changes in the amount (or level) of CPAP.

Interventions

DEVICEContinuous positive airway pressure (CPAP); level changes

as per arm description

Sponsors

Thrasher Research Fund
CollaboratorOTHER
Children's Hospital of Philadelphia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
24 Hours to 35 Weeks
Healthy volunteers
No

Inclusion criteria

1. Born at 27-35 weeks gestational age (GA) by best obstetric estimate, determined by the clinical obstetric team during antepartum admission. 2. Age limits: 24 hours of age - 35 weeks corrected gestational age. 3. On continuous CPAP support between 4-8 cm H2O for greater than 24 hours, as document on the bedside infant flow sheet. 4. Supplemental oxygen requirement, with a fraction of inspired oxygen (FiO2) 0.25 for at least 2 consecutive hours, as documented on the bedside infant flow sheet.

Exclusion criteria

1. Congenital anomalies, as determined by the clinical supervising physician. 2. Current or prior air leak syndrome, as determined by the clinical supervising physician.

Design outcomes

Primary

MeasureTime frameDescription
Ventilation/Perfusion Mismatchvariable; up to 2 hoursMeasured by non-invasive computerized technique based on curvilinear characteristics generated by a best-fit curve connecting the fractional inspired oxygen and corresponding peripheral oxygen saturation pairs; measured as difference in degree of right-shift between baseline and best CPAP

Secondary

MeasureTime frameDescription
Best CPAP Levelvariable, up to 2 hoursDefined as the lowest CPAP level associated with an improvement greater than 5% in V/Q mismatch relative to the preceding CPAP level

Countries

United States

Participant flow

Participants by arm

ArmCount
Continuous Positive Airway Pressure (CPAP) Level Changes
Protocol guided changes in CPAP level from clinical baseline, with responsiveness in V/Q mismatch guiding subsequent changes; limited to a range of -2 to +3 cm H2O from baseline Continuous positive airway pressure (CPAP); level changes: as per arm description
12
Total12

Baseline characteristics

CharacteristicContinuous Positive Airway Pressure (CPAP) Level Changes
Age, Continuous19 days
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
12 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
10 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
2 Participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 12
other
Total, other adverse events
0 / 12
serious
Total, serious adverse events
0 / 12

Outcome results

Primary

Ventilation/Perfusion Mismatch

Measured by non-invasive computerized technique based on curvilinear characteristics generated by a best-fit curve connecting the fractional inspired oxygen and corresponding peripheral oxygen saturation pairs; measured as difference in degree of right-shift between baseline and best CPAP

Time frame: variable; up to 2 hours

ArmMeasureValue (MEDIAN)
Continuous Positive Airway Pressure (CPAP) Level ChangesVentilation/Perfusion Mismatch1.2 difference in right shift (kPa)
Comparison: Within subject repeat analysis; V/Q mismatch (measured as degree of right shift in kPa) baseline vs best CPAPp-value: 0.02Sign test
Secondary

Best CPAP Level

Defined as the lowest CPAP level associated with an improvement greater than 5% in V/Q mismatch relative to the preceding CPAP level

Time frame: variable, up to 2 hours

ArmMeasureValue (MEDIAN)
Continuous Positive Airway Pressure (CPAP) Level ChangesBest CPAP Level7 cm H2O

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026